In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024
The list of nine-figure financings for private biotechs is starting to look like the scrolling receipts from CVS or Walgreens.
If that pace continues, it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
